year 17, Issue 4 (July - August 2023)                   Iran J Med Microbiol 2023, 17(4): 387-395 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Inamdar D P, Deshpande P U, Basavaraju A, Veerapu N. Fungal Rhinosinusitis: Study of Risk Factors, Outcome and Utility of Nasal Samples in Its Diagnosis. Iran J Med Microbiol 2023; 17 (4) :387-395
URL: http://ijmm.ir/article-1-1950-en.html
1- Department of Microbiology, Mamata Medical College and Hospital, Khammam, India , dhanashreeltmmc@gmail.com
2- Department of Microbiology, Mamata Medical College and Hospital, Khammam, India
3- Department of Community Medicine, Government Medical College (GMC), Anantapuramu, India
Abstract:   (1014 Views)

Background and Aim: Fungal rhinosinusitis (FRS) sets in following interactivity of fungi with Sino nasal tract when immune system is subdued. Due to varied clinical presentation of FRS with inconclusive evidence of imaging, mycological evaluation helps to identify and speciate the fungi .FRS can be diagnosed with biopsy tissue and/or deep nasal swabs. This study was undertaken to know risk factors, outcome along with utility of nasal samples with emphasis on deep nasal swabs in diagnosing fungal rhinosinusitis.
Materials and Methods: A retrospective observational study was carried out on patients with suspected fungal rhinosinusitis (invasive and non-invasive). Both COVID 19 positive and negative patients by RT-PCR were included. Brief clinical history, associated comorbidities, risk factors and outcome were noted in these cases.  Nasal swabs or tissue sample from endoscopic biopsy obtained from patients were subjected to Gram stain, KOH mount and culture on Sabouraud dextrose agar followed by slide culture for identification.
Results: Of the 41 cases studied for FRS, 25 were males and 16 females. Risk factors like Post COVID-19 infection was seen in 27(65.8%), diabetes in 31(75.6%) and use of steroid during COVID-19 treatment in 16(39.02%) cases. Deep nasal swabs were received in 29(70.7%) and tissue obtained after debridement in 12(29.3%) cases. Rhizopus spp was the most common fungi isolated followed by Aspergillus spp.
Conclusion: Both COVID and non-COVID patients were diagnosed with invasive/ non-invasive fungal rhinosinusitis from deep nasal swabs/tissue in the present study. Diabetes was an important comorbidity in non-COVID patients with FRS. Deep nasal swabs aided early diagnosis for both invasive and non-invasive FRS.

Full-Text [PDF 513 kb]   (336 Downloads) |   |   Full-Text (HTML)  (178 Views)  
Type of Study: Original Research Article | Subject: Medical Mycology
Received: 2023/02/4 | Accepted: 2023/08/8 | ePublished: 2023/09/27

References
1. Monga S, Malik JN, Sharma A, Agarwal D, Priya R, Naseeruddin K. Management of Fungal Rhinosinusitis: Experience From a Tertiary Care Centre in North India. Cureus. 2022;14(4):e23826. [DOI:10.7759/cureus.23826]
2. Fadda GL, Succo G, Moretto P, Veltri A, Castelnuovo P, Bignami M, et al. Endoscopic Endonasal Surgery for Sinus Fungus Balls: Clinical, Radiological, Histopathological, and Microbiological Analysis of 40 Cases and Review of the Literature. Iran J Otorhinolaryngol. 2019;31(102):35-44.
3. Deutsch PG, Whittaker J, Prasad S. Invasive and Non-Invasive Fungal Rhinosinusitis-A Review and Update of the Evidence. Medicina. 2019;55(7):319. [DOI:10.3390/medicina55070319] [PMID] [PMCID]
4. Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J, Buzina W, Kita H, et al. Fungal rhinosinusitis A categorization and definitional schema addressing current controversies. Laryngoscope. 2009;119(9):1809-18. [DOI:10.1002/lary.20520] [PMID] [PMCID]
5. Palanisamy P, Elango D. COVID19 associated mucormycosis: A review. J Family Med Prim Care. 2022;11(2):418-23. [DOI:10.4103/jfmpc.jfmpc_1186_21] [PMID] [PMCID]
6. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. Laryngol Otol. 2021;135(5):442-7. [DOI:10.1017/S0022215121000992] [PMID] [PMCID]
7. Gupta SK, Singh R, Gupta A. Incidence of Fungal Rhinosinusitis in Bihar and Its Management. Int J Res Rev. 2018;5(11):196-201.
8. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006;44(4):335-42. [DOI:10.1080/13693780500464930] [PMID]
9. Aranjani JM, Manuel A, Abdul Razack HI, Mathew ST. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLOS Negl Trop Dis. 2021;15(11):e0009921. [DOI:10.1371/journal.pntd.0009921] [PMID] [PMCID]
10. Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, et al. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. J Fungus. 2021;8(1):44. [DOI:10.3390/jof8010044] [PMID] [PMCID]
11. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am. 2000;33(2):349-65. [DOI:10.1016/S0030-6665(00)80010-9] [PMID]
12. Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009;85(1009):573-81. [DOI:10.1136/pgmj.2008.076463] [PMID]
13. Philip AC, Madan P, Sharma S, Das S. Utility of MGG and Papanicolaou stained smears in the detection of Mucormycosis in nasal swab/scraping/biopsy samples of COVID 19 patients. Diagn Cytopatho. 2022;50(3):93-8. [DOI:10.1002/dc.24924] [PMID] [PMCID]
14. Salehi M, Ahmadikia K, Badali H, Khodavaisy S. Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran. Mycopathologia. 2020;185(4):607-11. [DOI:10.1007/s11046-020-00472-7] [PMID] [PMCID]
15. Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021;9(8):e77. [DOI:10.1016/S2213-2600(21)00265-4] [PMID]
16. Frater JL, Hall GS, Procop GW. Histologic Features of Zygomycosis: Emphasis on Perineural Invasion and Fungal Morphology. Arch Pathol Lab Med. 2001;125(3):375-8. [DOI:10.5858/2001-125-0375-HFOZ] [PMID]
17. Sreshta K, Dave TV, Varma DR, Nair AG, Bothra N, Naik MN, et al. Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. 2021;69(7):1915-27. [DOI:10.4103/ijo.IJO_1439_21] [PMID] [PMCID]
18. Hernández JL, Buckley CJ. Mucormycosis.[Updated 2020 Jun 26]. Stat Pearls [Internet] Treasure Island (FL): Stat Pearls Publishing. 2021.
19. Kewaliya R, Yadav DK, Lunia G, Jangir S. A clinicoepidemiological study of orbital mucormycosis in COVID-19 pandemic at a tertiary healthcare hospital, North-West Rajasthan, India. Delta J Ophthalmol. 2022;23(3):213-20. [DOI:10.4103/djo.djo_6_22]
20. Ahirwar SS. Emerging cases of mucormycosis in post Covid-19 disease patients. Indian J Microbiol Res. 2021;8(3):219-23. [DOI:10.18231/j.ijmr.2021.045]
21. Kumar DSS, Singh R. To evaluate the mucormycosis cases in post Covid-19 patients. Eur J Mol Clin Med. 2022;9(3):134-8.
22. Gade N, Nag S, Shete V, Mishra M. Study of Molds in Post COVID -19 Patients: An experience from Tertiary Care Centre. J Infect Dis Microbiol. 2022;1(2):1-7. [DOI:10.37191/Mapsci-JIDM-1(1)-007]
23. Meher R, Wadhwa V, Kumar V, Shisha Phanbuh D, Sharma R, Singh I, et al. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi. Am J Otolaryngol. 2022;43(1):103220. [DOI:10.1016/j.amjoto.2021.103220] [PMID] [PMCID]
24. Hapugoda S, Jones J, Hacking C, et al. Hiatus semilunaris. 2022.
25. Farghly Youssif S, Abdelrady MM, Thabet AA, Abdelhamed MA, Gad MOA, Abu-Elfatth AM, et al. COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma. Sci Rep. 2022;12(1):13443-3. [DOI:10.1038/s41598-022-13443-3] [PMID] [PMCID]
26. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459-68. [DOI:10.1093/cid/ciaa530] [PMID] [PMCID]
27. Shetty S, Shilpa C, Kavya S, Sundararaman A, Hegde K, Madhan S. Invasive Aspergillosis of Nose and Paranasal Sinus in COVID-19 Convalescents: Mold Goes Viral? Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):3239-44. [DOI:10.1007/s12070-022-03073-6] [PMID] [PMCID]
28. Abdollahi A, Shokohi T, Amirrajab N, Poormosa R, Kasiri AM, Motahari SJ, et al. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis. Curr Med Mycol. 2016;2(4):15-23. [DOI:10.18869/acadpub.cmm.2.4.15] [PMID] [PMCID]
29. Dufour X, Kauffmann-Lacroix C, Ferrie JC, Goujon JM, Rodier MH, Klossek JM. Paranasal sinus fungus ball: epidemiology, clinical features and diagnosis. A retrospective analysis of 173 cases from a single medical center in France, 1989-2002. Sabouraudia. 2006;44(1):61-7. [DOI:10.1080/13693780500235728] [PMID]
30. Nazari T, Sadeghi F, Izadi A, Sameni S, Mahmoudi S. COVID-19-associated fungal infections in Iran: A systematic review. PLoS One. 2022;17(7):e0271333. [DOI:10.1371/journal.pone.0271333] [PMID] [PMCID]
31. Chaganti P, Rao N, Devi K, Janani B, Vihar P, Neelima G. Study of fungal rhinosinusitis. J NTR Univ Health Sci. 2020(9):103-6. [DOI:10.4103/JDRNTRUHS.JDRNTRUHS_98_20]
32. Waghray J. Clinical study of fungal sinusitis. Int J Otorhinolaryngol Head Neck Surg. 2018;4(5):1307-12. [DOI:10.18203/issn.2454-5929.ijohns20183707]
33. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungus. 2020;6(4):265. [DOI:10.3390/jof6040265] [PMID] [PMCID]
34. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin. 2016;30(1):143-63. [DOI:10.1016/j.idc.2015.10.011] [PMID]
35. Gupta MK, Kumar N, Dhameja N, Sharma A, Tilak R. Laboratory diagnosis of mucormycosis: Present perspective. Fam Med Prim Care Rev. 2022;11(5):1664-71. [DOI:10.4103/jfmpc.jfmpc_1479_21] [PMID] [PMCID]
36. Watkinson JC, Clarke RW. Scott-Brown's Otorhinolaryngology and Head and Neck Surgery. Basic Sciences, Endocrine Surgery, Rhinology. 1. USA: CRC Press: Boca Raton, FL; 2018. [DOI:10.1201/9780203731000]
37. Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a Viral Land: A Tale of Two Pathogens. Indian J Ophthalmol. 2021;69(2):244-52. [DOI:10.4103/ijo.IJO_3774_20] [PMID] [PMCID]
38. Honavar SG. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19. Indian J Ophthalmol. 2021;69(6):1361-5. [DOI:10.4103/ijo.IJO_1165_21] [PMID] [PMCID]
39. Baghel SS, Keshri AK, Mishra P, Marak R, Manogaran RS, Verma PK, et al. The spectrum of invasive fungal sinusitis in COVID-19 patients: experience from a tertiary care referral center in Northern India. J Fungus. 2022;8(3):223. [DOI:10.3390/jof8030223] [PMID] [PMCID]
40. Centers for Disease Control and Prevention. Mucormycosis statistics. 2022.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc